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Majority of gynaecological, proctologic diseases were treated through rectal or vaginal delivery of medica-
tions, which can bypass the first pass metabolism and can produce required local effect. Inserts are evolu-
tionary pharmaceutical dosageform that are semi solid at room temperature but upon insertion in cavities 
of humans, melt and release the drug localised. The inserts are advantageous since they can be placed at 
scare sites where blood perfusion is high that can enable for rapid absorption limiting many side effects. 
Ocular inserts represents the advanced technology in treating several ophthalmic diseases. Designing and 
development of optimum inserts is a challenge ever faced by Pharmaceutical researchers. In view of this, 
lipid and polymer based systems were additionally employed to improve the therapeutic efficiency of fore-
said dosage forms. The review rationalises the importance of these inserts and their broad applications for 
multidisciplinary applications.   
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INTRODUCTION 
Active pharmaceutical ingredients (API) can be ad-
ministered through a variety of routes, the widely 
used one is the oral followed by parenteral route. [1,2] 
In spite of long history of use of medications in the 
rectal and vaginal suppositories/pessaries form, they 
are less commonly used and the global market is also 
limited due to patient incompliance. 
On the other hand, suppositories have several bene-
fits, especially in the treatment of gynaecological, 
proctological diseases.[3,4] API mix with various bases 
and this interaction can provide satisfactory pharma-
cokinetics with acceptable tolerance.  
The eye as a portal for drug delivery is generally used 
for local therapy against systemic therapy to avoid 
the risk of eye damage from high blood concentra-
tions of the drug, which is not intended.[5] The excep-
tional anatomy and physiology of the eye make the 
organ impervious to the foreign substances, conse-
quently posing the challenge to the formulator in 
overcoming of these protective layers without caus-
ing any permanent damage to the local tissues. Con-
trolled release principles can be effectively applied in 
designing ocular inserts as an important approach in 
prolonging the drug residence time. Inserts are avail-
able in different shapes and sizes (Figure 1) [6]. In the 
present review, various methodologies for designing 
of insert such as suppositories/pessaries and ocular 
inserts were described in relation to several li-
pid/polymer based systems.  
 
Figure 1: Various sizes and shapes of Suppositories 
Types and designing of inserts 
Suppositories are designed to deliver the medications 
through rectal and vaginal routes. Initially, they 
evolved as a more convenient form instead of liquid 
enema. Pessaries are frequently described as vaginal 
suppositories. These dosage forms were exhibited 
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several advantages- local effect on rectal mucosa; can 
be used effectively in pediatric, geriatric, unconscious 
patients; can also used for systemic benefit and 
avoids gastrointestinal irritation. Despite of all these, 
suppositories are few limitations such as patient ac-
ceptance, incomplete absorption and irritation to mu-
cosa. Several local host factors may influence absorp-
tion in the rectum: the mucus layer, volume of rectal 
fluid, cell membrane, the tight junctions and the intra-
cellular compartments arethe local barriers for ab-
sorption. The suppository bases should have certain 
physico-chemical properties and significant effect on 
the uniformity and dosing of API [3]. According to 
United States Pharmacopeia, there are six main clas-
ses of bases like [7-10] Cocoa butter, Glycerin gelatin, 
Polyethylene glycol, Cocoa butter substitutes, Surfac-
tant basis and tablet suppositories or inserts. In some 
other sources, classification was done on basis of 
melting dissolution. Ocular inserts are the solid or 
semisolid preparations designed for ophthalmic 
preparations and these were placed in lower fornix 
and less commonly in upper fornix and cornea. These 
are usually fabricated with polymeric vehicle con-
taining drug. Several advantages and disadvantages 
of ocular inserts were given in Figure 2.  
 
Figure 2: Advantages and disadvantages of ocular in-
serts 
Polymers used for fabrication of ocular inserts; hy-
droxy propyl cellulose, poly vinyl pyrrolidone, hyalu-
ronic acid, ethylene vinyl acetate, alginatemeudragit-
rs, collagen, polypeptide, ethyl cellulose and cellulose 
acetate pthalate [11-16]. Ocular inserts are majorily 
classified into Insoluble ocular inserts, Soluble ocular 
inserts and Bioerodibleocular inserts. 
Application of Lipid/polymer based systems 
Many significant efforts have been tried for the poten-
tial application of lipid-based drug delivery systems 
(LBDS), to provide the required site specific con-
trolled release of wide range of drugs and bioactive 
agents by improving their solubility. These systems 
includes several novel drug delivery systems like na-
noparticles, microspheres, mucoadhesion [17-37], lipo-
some and nanofibers etc [38-59]. Application of these 
systems and polymers to overcome the drawbacks 
associated with inserts are studied. Several polymers 
like Chitosan, Alginate, PLGA, Polyvinylpyrrolidone, 
Zein ad Okra were used successfully. Additionally 
solid dispersion methodology is applied to enhance 
the solubility of Class II drugs [60-65]. Response surface 
methodology is applied to optimize the process pa-
rameters in the formulation of these systems [66-70]. 
Formulated LBDS are made into suppositories or in-
sert to further enhance the residence time, thus fi-
nally improving the bioavailability.  
Therapeutic areas 
Inserts can be loaded with wide range of drugs like, 
Local Anesthetics, Protectants, Steroids, Astringents, 
Vasoconstrictors, Antiseptics, keratolytics, Anti-glau-
coma, anti-bacterial and Anti-inflammatory etc.  
CONCLUSION 
Inserts were found to advantageous as it can elimi-
nate several drawbacks associated with conventional 
drug delivery system. Application of lipid or polymer 
based systems, can further enhance the effectiveness 
of these systems in terms of residence time and bioa-
vailability. However, polymer or lipid incompatibili-
ties should be governed and careful preformulation 
studies need to be conducted. The safe and toxicolog-
ical studies are strong advised for moving the product 
either to the preclinical or clinical trial phases. The 
importance of inserts lies in pediatric or geriatric pa-
tience indicating high compliance and minimal super-
vision since it is very safe to use.  
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